Patients
2.2 per 100,000 people
Suicide rate, Saudi Arabia, 2023 (WHO).
Compare every country on the Public Health Dashboard
Updated
Reviewed by Vidhi Upadhyay
Saudi Arabia Schizophrenia Drugs Market Industry Trends and Forecast to 2034: Segmented by (Drug Class, Route, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$120.0 Mn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $139.1 Mn | — | — |
| 2025 (base) | $148.5 Mn | +$9.5 Mn | — |
| 2026 (forecast) | $158.6 Mn | +$10.1 Mn | +6.8% |
| 2027 (forecast) | $169.4 Mn | +$10.8 Mn | +14.1% |
| 2028 (forecast) | $180.9 Mn | +$11.5 Mn | +21.8% |
| 2029 (forecast) | $193.2 Mn | +$12.3 Mn | +30.1% |
| 2030 (forecast) | $206.4 Mn | +$13.1 Mn | +38.9% |
| 2031 (forecast) | $220.4 Mn | +$14.0 Mn | +48.4% |
| 2032 (forecast) | $235.4 Mn | +$15.0 Mn | +58.5% |
| 2033 (forecast) | $251.4 Mn | +$16.0 Mn | +69.3% |
| 2034 (forecast) | $268.5 Mn | +$17.1 Mn | +80.8% |
Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
| Market size, 2025 | $148.5 Mn placeholder estimate |
|---|---|
| Forecast, 2034 | $268.5 Mn placeholder estimate |
| Growth (CAGR), 2025–2034 | 6.8% placeholder estimate |
| Years | 2024 historical · 2025 base year · 2026–2034 forecast |
| Segments | Drug class, route and end user (see all) |
| Key players | Johnson & Johnson, Otsuka Pharmaceutical Co., Ltd., Bristol-Myers Squibb, Teva Pharmaceutical, AbbVie Inc. (see all) |
| Regulator in Saudi Arabia | SFDASource: Saudi Food and Drug Authority. Checked 14 Nov 2026. |
| Formats | PDF, PPTX, XLSX |
Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.
Schizophrenia drugs control symptoms such as hallucinations and delusions, including long-acting injectables and new non-dopamine medicines.
Key segments of the schizophrenia Drugs market include drug class (Second-Generation Antipsychotics, Long-Acting Injectables and Muscarinic Agonists) and route (Oral and Injectable).
More people seeking help for mental health, less stigma, better screening and new treatments with faster effects are driving the schizophrenia Drugs market. Governments and employers are investing more in mental health care.
Digital tools, new drug classes and care built into primary care and workplaces give the schizophrenia Drugs market strong room to grow worldwide.
Shortages of mental health professionals, limited insurance coverage, side effects and the need for long-term treatment hold back the schizophrenia Drugs market.
The schizophrenia Drugs market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
The Saudi Food and Drug Authority (SFDA) registers medicines before sale.[1] Citizens get free public care through the Ministry of Health, while most expatriate workers must have private health insurance, regulated by the Council of Health Insurance (CHI).[2] Suicide rate: 2.2 per 100,000 people in 2023, the latest WHO figure for Saudi Arabia.[3]
[1] Saudi Food and Drug Authority. Checked 14 Nov 2026.
[2] Council of Health Insurance. Checked 14 Nov 2026.
[3] WHO Global Health Observatory, Suicide rate (per 100,000 people). Retrieved 20 Nov 2026.
Regulators such as the US FDA, the European Medicines Agency and national drug authorities set approval, pricing and safety rules for schizophrenia Drugs. Reimbursement decisions by public payers and insurers shape how fast new therapies reach patients in Saudi Arabia.
What doctors and scientists are doing in Schizophrenia Drugs right now, from free public sources.
2.2 per 100,000 people
Suicide rate, Saudi Arabia, 2023 (WHO).
Compare every country on the Public Health DashboardSources: PubMed (US National Library of Medicine), ClinicalTrials.gov, WHO Global Health Observatory, World Bank. Fetched 20 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
[1] WHO Global Health Observatory, Suicide rate (per 100,000 people). Retrieved 19 Nov 2026.
[2] World Bank Open Data, Health spending per person (US$ per person). Retrieved 19 Nov 2026.
[3] World Bank Open Data, Doctors (per 1,000 people). Retrieved 19 Nov 2026.
From our blog
Saudi Arabia · 2 shared keywords
Saudi Arabia · 2 shared keywords
Saudi Arabia · 2 shared keywords
Saudi Arabia · 2 shared keywords
Saudi Arabia · 2 shared keywords
Saudi Arabia · 2 shared keywords
OTC & Nutraceuticals · Saudi Arabia
Digital Health · Saudi Arabia
Digital Health · Saudi Arabia
OTC & Nutraceuticals · Saudi Arabia
Healthcare Services · Saudi Arabia
Public Health · Saudi Arabia